On news the two companies received US FDA “fast track” status, PFE exploded from $34.63 to a current price of $35.50. PFE is still a solid opportunity as it races to produce a vaccine.
BioNTech (BNTX) ran from $78.38 to $77.78, and is set to open at $81.96 this morning.
If you bought into these trades, we’d love to hear how you’re doing with them so far.
As for new opportunities, Moderna (MRNA) is offering us big opportunity again. Even after running nearly $10 higher yesterday, the stock could see higher highs after a Jefferies analyst began coverage of MRNA with a buy rating and a $90 price target.
“We believe the Street will be surprised to the upside if the Covid-19 vaccine works, gets approved by early 2021, and there are multi-billion dollars of purchase orders from USA and around the world,” they noted.